Tautachrome (OTCQB: TTCM) Announces Official Issuance of its KlickZie Authentication Patent
Mar 01, 2017 12:01 pm UTC| Business
ORO VALLEY, Ariz., March 01, 2017 -- Tautachrome, Inc. (OTCQB:TTCM) today announced the issuance of its wholly owned US Patent number 9,582,843, a key KlickZie technology patent aimed at the authentication of smartphone...
Zosano Pharma Reports Fourth Quarter and Fiscal 2016 Financial Results and Business Update
Mar 01, 2017 12:01 pm UTC| Business
FREMONT, Calif., March 01, 2017 -- Zosano Pharma Corporation (NASDAQ:ZSAN), an emerging central nervous system company focused on providing symptom relief to patients using the Company's proprietary intracutaneous...
Mar 01, 2017 12:01 pm UTC| Business
RESTON, Va., March 01, 2017 -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear fuel technology company, today announced that it has been invited to present at two upcoming events at the Massachusetts Institute of...
Mar 01, 2017 12:01 pm UTC| Business
NIWOT, Colo., March 01, 2017 -- Crocs, Inc. (NASDAQ:CROX) today reported financialresults for the fourth quarter and year ended December31, 2016. Fourth Quarter Highlights: Revenues were in line with guidance at...
Akorn Provides Fourth Quarter and Full Year 2016 Results and Outlines Full Year 2017 Guidance
Mar 01, 2017 12:01 pm UTC| Business
- Q4 2016 Revenue Increase to $284 Million - - Q4 2016 GAAP Diluted EPS Decrease of 4% to $0.26; Q4 2016 Adjusted Diluted EPS Decrease of 3% to $0.58 - - FY 2016 Revenue Increase of 13% to $1,117 Million - - FY 2016...
Amicus Therapeutics Announces Full-Year 2016 Financial Results and Corporate Updates
Mar 01, 2017 12:01 pm UTC| Business
Growing Momentum for EU Galafold (Migalastat) Launch for Fabry Disease Tracking Toward 300 Patients by Year-End 2017 Target Enrollment Achieved in Phase 1/2 Pompe Study – Additional Data Expected in 2Q17 and 3Q17 Phase...
Mar 01, 2017 12:01 pm UTC| Business
NEW YORK, March 01, 2017 -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced its financial...